The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The efficacy and safety of combined chinese herbal medicine and western medicine therapy for COVID-19: a systematic review and meta-analysis
Authors
Keywords
-
Journal
Chinese Medicine
Volume 17, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-21
DOI
10.1186/s13020-022-00600-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Research progress of traditional Chinese medicine against COVID-19
- (2021) Wei Ren et al. BIOMEDICINE & PHARMACOTHERAPY
- Chinese herbal medicine (“3 medicines and 3 formulations”) for COVID ‐19: rapid systematic review and meta‐analysis
- (2021) Yangzihan Wang et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial
- (2021) Chang Chen et al. Frontiers in Pharmacology
- Efficacy of Integrated Traditional Chinese and Western Medicine for Treating COVID-19: A Systematic Review and Meta-Analysis of RCTs
- (2021) Bei Yin et al. Frontiers in Public Health
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19
- (2020) Shahnaz Sultan et al. GASTROENTEROLOGY
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial
- (2020) Ke Hu et al. PHYTOMEDICINE
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Treatment for severe acute respiratory distress syndrome from COVID-19
- (2020) Michael A Matthay et al. Lancet Respiratory Medicine
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Herbal Medicine for the Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2020) Lin Ang et al. Journal of Clinical Medicine
- Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
- (2020) Florian Slimano et al. CANCER TREATMENT REVIEWS
- Review of adverse cutaneous reactions of pharmacologic interventions for coronavirus disease 2019 (COVID-19): a guide for the dermatologist
- (2020) Antonio Martinez-Lopez et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Development of anti‐influenza agents from natural products
- (2020) Zhi‐Jun Zhang et al. MEDICINAL RESEARCH REVIEWS
- Efficacy and Safety of Integrated Traditional Chinese and Western Medicine for Corona Virus Disease 2019 (COVID-19): a systematic review and meta-analysis
- (2020) Ming Liu et al. PHARMACOLOGICAL RESEARCH
- The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence
- (2020) Dan Zhang et al. PHARMACOLOGICAL RESEARCH
- The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis
- (2020) Xufei Luo et al. PHYTOMEDICINE
- Combating COVID-19 with integrated traditional Chinese and Western medicine in China
- (2020) Liqiang Ni et al. Acta Pharmaceutica Sinica B
- Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China
- (2020) Yong-an Ye et al. Frontiers in Medicine
- Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis
- (2020) Arthur Yin Fan et al. Journal of Integrative Medicine-JIM
- Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a
- (2020) Jie Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
- (2020) Siyi Xin et al. BIOMEDICINE & PHARMACOTHERAPY
- A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
- (2020) Alexander Simonis et al. EMBO Molecular Medicine
- Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
- (2020) Pierre-François Dequin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review
- (2020) Zhenyu Zhao et al. PHYTOMEDICINE
- Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis
- (2020) David Y.W. Lee et al. PHYTOMEDICINE
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Dynamics of the COVID-19 basic reproduction numbers in different countries
- (2020) TianXiang Yue et al. Science Bulletin
- Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis
- (2020) Meng Wang et al. BMJ Supportive & Palliative Care
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- The Effects of Traditional Chinese Medicine as an Auxiliary Treatment for COVID-19: A Systematic Review and Meta-analysis
- (2020) Le-peng Zhou et al. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE
- Oxford–AstraZeneca COVID-19 vaccine efficacy
- (2020) Maria Deloria Knoll et al. LANCET
- Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
- (2020) Min Seo Kim et al. PLOS MEDICINE
- Development of the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Summary of Findings (SoF) Table for Network Meta-analysis
- (2019) Juan José Yepes-Nuñez et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis
- (2018) Romina Brignardello-Petersen et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range
- (2015) Xiang Wan et al. BMC Medical Research Methodology
- A herbal formula consisting of Rosae Multiflorae Fructus and Lonicerae Japonicae Flos inhibits inflammatory mediators in LPS-stimulated RAW 264.7 macrophages
- (2014) Brian Chi-Yan Cheng et al. JOURNAL OF ETHNOPHARMACOLOGY
- A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
- (2014) M. A. Puhan et al. BMJ-British Medical Journal
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started